T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Intellia Therapeutics
NTLA
$1.21B
| $55.9M | 0.01% |
1,834,143
-215,077
| -10% | -$6.56M |
|
677
Incyte
INCY
$16.8B
| $55.9M | 0.01% |
890,506
-159,652
| -15% | -$10M |
|
678
Huntsman Corp
HUN
$1.88B
| $55.4M | 0.01% |
2,205,196
+2,092,948
| +1,865% | +$52.6M |
|
679
Sociedad Química y Minera de Chile
SQM
$12B
| $55.3M | 0.01% |
917,477
+378,081
| +70% | +$22.8M |
|
680
Denali Therapeutics
DNLI
$2.14B
| $55.2M | 0.01% |
2,574,321
-317,629
| -11% | -$6.82M |
|
681
Hershey
HSY
$37.6B
| $55.2M | 0.01% |
296,229
-1,673,369
| -85% | -$312M |
|
682
Realty Income
O
$54.4B
| $55.1M | 0.01% |
960,209
+19,746
| +2% | +$1.13M |
|
683
DoubleVerify
DV
$2.26B
| $54.9M | 0.01% |
1,492,610
-39,579
| -3% | -$1.46M |
|
684
Oneok
OKE
$46.2B
| $54.8M | 0.01% |
780,649
+6,098
| +0.8% | +$428K |
|
685
Global X Copper Miners ETF NEW
COPX
$2.17B
| $54.5M | 0.01% |
+1,454,595
| New | +$54.5M |
|
686
Dow Inc
DOW
$16.9B
| $54.3M | 0.01% |
990,356
+51,751
| +6% | +$2.84M |
|
687
CRISPR Therapeutics
CRSP
$4.71B
| $54.1M | 0.01% |
864,346
-5,291
| -0.6% | -$331K |
|
688
CorVel
CRVL
$4.39B
| $53.9M | 0.01% |
654,465
-11,325
| -2% | -$933K |
|
689
Skyworks Solutions
SWKS
$10.9B
| $53.9M | 0.01% |
479,164
+170,908
| +55% | +$19.2M |
|
690
Xcel Energy
XEL
$42.8B
| $53.7M | 0.01% |
868,126
-305,671
| -26% | -$18.9M |
|
691
Occidental Petroleum
OXY
$45.6B
| $53.5M | 0.01% |
895,218
+7,140
| +0.8% | +$426K |
|
692
Cleveland-Cliffs
CLF
$5.62B
| $53.3M | 0.01% |
2,608,984
+2,319,486
| +801% | +$47.4M |
|
693
Krystal Biotech
KRYS
$3.98B
| $53M | 0.01% |
427,363
+171,157
| +67% | +$21.2M |
|
694
Estee Lauder
EL
$31.5B
| $52.8M | 0.01% |
361,303
-2,131,654
| -86% | -$312M |
|
695
Archer Daniels Midland
ADM
$29.5B
| $52.5M | 0.01% |
726,620
+7,699
| +1% | +$556K |
|
696
CBIZ
CBZ
$3.01B
| $52.2M | 0.01% |
834,708
-27,091
| -3% | -$1.7M |
|
697
General Mills
GIS
$26.7B
| $52.2M | 0.01% |
800,832
-2,677,887
| -77% | -$174M |
|
698
Super Micro Computer
SMCI
$26.1B
| $52M | 0.01% |
1,829,050
+636,540
| +53% | +$18.1M |
|
|
CRGX
699
DELISTED
CARGO Therapeutics
CRGX
| $51.8M | 0.01% |
+2,238,507
| New | +$51.8M |
|
700
Grand Canyon Education
LOPE
$5.69B
| $51.7M | 0.01% |
391,859
-28,271
| -7% | -$3.73M |
|